Recombinant human keratinocyte growth factor-2 - Anhui Anke Biotechnology

Drug Profile

Recombinant human keratinocyte growth factor-2 - Anhui Anke Biotechnology

Alternative Names: FGF-10 - Anhui Anke Biotechnology; rhKGF-2 - Anhui Anke Biotechnology

Latest Information Update: 26 Nov 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Newsummit Biopharma
  • Developer Anhui Anke Biotechnology
  • Class Fibroblast growth factors
  • Mechanism of Action Fibroblast growth factor stimulants; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Clinical Phase Unknown Wounds

Most Recent Events

  • 25 Nov 2015 Clinical trials in Wounds in China (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top